Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill C Mwenifumbo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Reviews. Genetics|April 19, 2013
Cancer genome-sequencing study designJill C Mwenifumbo, Marco A Marra
Pharmacogenomics|November 6, 2007
Genetic variability in CYP2A6 and the pharmacokinetics of nicotineJill C Mwenifumbo, Rachel F Tyndale
Handbook of Experimental Pharmacology|February 3, 2009
Molecular genetics of nicotine metabolismJill C Mwenifumbo, Rachel F Tyndale
Drug and Alcohol Dependence|December 13, 2006
Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smokingJill C Mwenifumbo, Edward M Sellers, Rachel F Tyndale
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 8, 2008
Socioeconomic and drug use determinants of smoking status in an urban adult population of Black African descentJill C Mwenifumbo, Edward M Sellers, Rachel F Tyndale
Pharmacogenomics|February 9, 2010
New CYP2A6 gene deletion and conversion variants in a population of Black African descentJill C Mwenifumbo, Qian Zhou, Neal L Benowitz, et al.
Pharmacogenetics and Genomics|January 25, 2008
A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descentMan Ki Ho, Jill C Mwenifumbo, Bin Zhao, et al.
European Journal of Clinical Pharmacology|June 8, 2006
Characterization of the novel CYP2A6*21 allele using in vivo nicotine kineticsNael Al Koudsi, Jill C Mwenifumbo, Edward M Sellers, et al.
Pharmacogenetics and Genomics|April 30, 2005
Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping methodJill C Mwenifumbo, Mark G Myers, Tamara L Wall, et al.
Human Mutation|March 25, 2008
Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descentJill C Mwenifumbo, Nael Al Koudsi, Man Ki Ho, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Reviews. Genetics|April 19, 2013
Cancer genome-sequencing study designJill C Mwenifumbo, Marco A Marra
Pharmacogenomics|November 6, 2007
Genetic variability in CYP2A6 and the pharmacokinetics of nicotineJill C Mwenifumbo, Rachel F Tyndale
Handbook of Experimental Pharmacology|February 3, 2009
Molecular genetics of nicotine metabolismJill C Mwenifumbo, Rachel F Tyndale
Drug and Alcohol Dependence|December 13, 2006
Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smokingJill C Mwenifumbo, Edward M Sellers, Rachel F Tyndale
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 8, 2008
Socioeconomic and drug use determinants of smoking status in an urban adult population of Black African descentJill C Mwenifumbo, Edward M Sellers, Rachel F Tyndale
Pharmacogenomics|February 9, 2010
New CYP2A6 gene deletion and conversion variants in a population of Black African descentJill C Mwenifumbo, Qian Zhou, Neal L Benowitz, et al.
Pharmacogenetics and Genomics|January 25, 2008
A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descentMan Ki Ho, Jill C Mwenifumbo, Bin Zhao, et al.
European Journal of Clinical Pharmacology|June 8, 2006
Characterization of the novel CYP2A6*21 allele using in vivo nicotine kineticsNael Al Koudsi, Jill C Mwenifumbo, Edward M Sellers, et al.
Pharmacogenetics and Genomics|April 30, 2005
Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping methodJill C Mwenifumbo, Mark G Myers, Tamara L Wall, et al.
Human Mutation|March 25, 2008
Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descentJill C Mwenifumbo, Nael Al Koudsi, Man Ki Ho, et al.
Pageof 2